|
Professional organizations, ix-x Progesterone, 168, 169, 170, Progestin, 177 Prolactin-release inhibitors, 173 Promethazine Phenergan ; , 96 Prophylactic therapy alternative to pain-relief measures, ix for cluster headaches, 122-123, 124-125, 126t, for coexisting migraine and tension-type headaches, 144, 145 for migraines see Migraines: treatment, pharmacologic for: prophylactic therapy ; during nursing, 176 for post-traumatic headaches, 186 pregnancy contraindications for, 175 for tension-type headaches, 139, 142 Propranolol Inderal, Inderal LA ; , 51, 98t, 99-100, Prostraglandin inhibitors, 173 Prostration, 146t Protriptyline, 139, 141t, 162 Pseudomotor cerebri, 152-153 Pseudotumor syndrome, 44 Psychiatric disease, 146t Psychiatric evaluation, 138 Psychiatric therapies, 175 Psychic symptoms in chronic, tension-type headache patients, 22, 136 Psychic symptoms in elderly, 161, 163t Psychological counseling, 51, 52, 142, Psychological inventory, 135 Psychological testing, 158 Ptosis, 26, 46, 121t, Pulse, controlling, 108 Pupillary dilation, 184 Radiofrequency rhizotomy, 49, 50t Radiologic examinations, 33 Rash as meningitis symptom, 41, 195 Refractive errors, 151 Reglan. See Metoclopramide Reglan ; 230.
The list of trials showing some details of their characteristics, for example, number of investigators, number of patients, dose of medication, are given in Tables 1a and 1b further details and references of published trials can be obtained from the authors upon request ; . One trial nonUSA10 ; was excluded after the initial analyses which showed that the trial was responsible for a statistically significant heterogeneity, and inspection of the results suggested that they were unlike the others i.e., partial HDRS17 response rates were 86.7% and 6.7% for the fluoxetine-treated and TCA-treated groups, respectively ; . For the USA-trial analysis, data were analysed from 16 single- and multicentre, randomised, double-blind trials involving 3543 patients see Table 1a ; . Of the 3447 patients, 1914 had received fluoxetine, 847 had.
CHVP: cyclophosphamide d1, doxorubicin d1, etoposide d1, prednisone d15 [18]. b ACVBP: cyclophosphamide d1, doxorubicin d1, vindesine d1 and d5, bleomycine d1 and d5, prednisone d1 to d5 [19]. c CHOP: cyclophosphamide d1, doxorubicin d1, vincristine d1, prednisone d1 to d5 [20]. d Hyper-CVAD: course 1 ; cyclophosphamide d13, doxorubicin d4 and d5, vincristine d4 and d11, dexamethasone d14 and d1114; course 2: methotrexate d1, aracytine d2 and d3 [2]!
Results: The overall response rate at 12 weeks was 67% 21% complete remission CR with a median overall survival Background: Although lymphoid malignancies are generally of 13 months. A symptomatic response was seen in 72%. chemosensitive, relapse is common. The use of high-dose Previous high-dose therapy did not compromise the response therapy can make subsequent cytotoxic therapy intolerable. rate. Toxicity was acceptable with grade 3-4 haematological There is a need to develop regimens with low acute toxicity toxicity seen in 27% of cycles, gastrointestinal toxicity seen in which are suitable for use in patients post-high dose therapy 11% and pulmonary toxicity seen in 8%. Thirty-one percent of and following the failure of standard protocols. patients required hospitalisation at some point during this Patients and methods: Twenty-six patients with lymphomas, treatment most commonly for neutropenic sepsis. fifteen of whom had received high-dose therapy, were treated Conclusions: LBCMVD-56 is an inexpensive, outpatientwith a novel regimen consisting of low-dose lomustine, based regimen with low acute toxicity and a high response rate chlorambucil, daily subcutaneous bleomycin, vincristine and in this heavily pre-treated group of patients. methotrexate with dexamethasone on an eight-week cycle LBCMVD-56 ; . A median of three cycles was given. Key words: low-dose continuous chemotherapy, lymphoma.
Vincristine wikipedia
Recent studies suggest that most cases of c h and angioedema are autoimmune. One of the f i r this was our recognition that autoimmune thyroiditis could be identified in about 14% of cases of chronic urticaria, which is a b three times the expected incidence.20 Other examples of p o diseases, such as vitiligo, alopecia areata, p e r n anemia, and adrenalitis, are also reported in patients with chronic urticaria. 20 D e evidence for the a u t etiology of chronic urticaria is derived from the studies of Hide et a 3 and confirmed and extended by Tong et a .4 They showed that about 60% of patients with chronic urticaria had circulating autoantibodies against the highaffinity IgE receptor FcERl, a subunit ; of mast cells. In vitro and in vivo, these cause mast cell activation analogous to the action of antibody on the thyroid-stimulating hormone receptors in Graves' disease. Other T-cell-derived mast cell and basophil cell activation mechanisms are also i n v such as synthesis of histamine-releasing factors and other cytokines. 21 The combined effect induces mast cell proliferation and the ingress of other inflammatory cells, such as basophils, activated T cells, and monocytes. Like autoimmune thyroiditis, the process can continue i n d wax and wane, or moderate spontaneously.
Home links contact us top 50 submit bookmark a b c translate this page in arabic chinese french german italian japanese korean portuguese russian spanish drug guide v vincristine sulfate vincristine sulfate vincristine sulfate vincristine-inj vincristine is one of a large group of drugs known as antineoplastics ; these drugs are also known as cancer drugs, chemotherapy, or chemo and vinorelbine.
The Maduganga estuary and mangrove islets are a complex coastal wetland ecosystem situated in the Galle District of Southern Sri Lanka. The total area of the estuary is 915 ha, of which 770 ha consist of open water, while islands account for 145 ha. With the view of safeguarding the ecological functions, resources and values of the Madu ganga estuary for conservation and future sustenance of biodiversity, IUCN Sri Lanka carried out a systematic assessment of biodiversity during a six-month period, from May to October 2000. Field monitoring of fauna and flora was carried out at fortnightly intervals, in a systematic manner, using scientifically accepted biodiversity assessment techniques. A zoning exercise was carried out according to ecological significance and threats to biodiversity, using appropriate indicators. The survey revealed that the Maduganga wetland consists of 10 major wetland vegetation types. These vegetation types harboured a total of 303 species of plants belonging to 95 families. The total plant species included 19 endemics, 8 nationally threatened species and 9 invasive alien species. Based on the extent of occurrence ha ; , mangroves and mangrove mixed swamps were the dominant wetland vegetation types in Maduganga. In addition to these wetland vegetation types, three major terrestrial vegetation types are also found in the islands and the surrounding mainland area of the Maduganga estuary. Perennial crops mainly cinnamon ; dominated the terrestrial vegetation types. A total of 98 plant species were recorded from the multi-species home gardens. When considering the species richness of flora in different wetland vegetation types, mangroves harboured the highest number of species, closely followed by mangrove mixed swamps. Maduganga estuary harbours a small population of a very rare, threatened mangrove species - Lumnitzera littorea. A total of 248 species of vertebrate fauna, belonging to 121 families were recorded from Maduganga. These included 20 species 8 % ; of endemics, while 30 species 12 % ; are nationally threatened. The native vertebrate fauna of Maduganga represents 30% of Sri Lanka's native inland vertebrate species. Maduganga, perhaps one of the last remaining tracts of pristine mangrove forest in Sri Lanka with a rich biodiversity, now appears to be threatened with the same predicament that many of the island's mangroves now find themselves in, owing to increasing human activity. At present, this wetland is not a protected area under any Government Department. Therefore, it is envisaged that the findings of this survey will contribute to the conservation of this unique coastal wetland. Key words: Maduganga mangrove estuary, biodiversity, threats.
Vincristine and siadh
Included high-dose HD ; methotrexate HD-MTX ; in 12 cases dose 3 g m2 course in 10 cases ; and CHOP cyclophosphamide adriamycin vincristine prednisone ; regimen in six. HD-MTX was combined with i ; HD-cytarabine, doxorubicin, cyclophosphamide and vincristine in six patients; ii ; procarbazine and vincristine in three cases; iii ; doxorubicin, cyclophosphamide and vincristine in two and iv ; thiotepa, nitrosourea and etoposide in one. Intrathecal CHT was used in 10 cases, MTX and cytarabine in eight, MTX alone in two. All patients received steroid therapy with a daily dose of 824 mg dexamethasone. Planned RT for patients with brain lesions consisted of whole brain irradiation 33 9 Gy, range 2050 Gy ; , followed or not followed by a tumour bed boost, with a mean tumour-bed dose of 45 5 range 30 60 Gy one patient without brain lesions received irradiation to the orbits only 50 Gy ; . The irradiation of the posterior two-thirds of the eyes was a part of the planned first-line treatment in 15 patients 37 6 Gy ; All patients were treated with 46 MeV photons and standard daily fractionation 1.82 Gy ; . All but four patients case Nos 1013 ; completed the planned treatment Table 2 ; . It had been planned that these patients were to receive CHTRT, but they were not irradiated due to early progression, toxic death n 2 ; or refusal. It had been planned for all four of these patients to receive ocular irradiation and viracept.
The substrate specificity of H6H has been studied in detail, the principal substrate in planta is S ; -hyoscyamine 58, there is no activity with the R-enantiomer.283 Many derivatives of tropine and nortropine are also hydroxylated to some extent by H6H; the best identified alternative substrates are benzotropine, benzoyltropine, 283 L-norhyoscyamine, phenylacetyltropine and L-homotropine.284 Some related tropane alkaloids found in the Solanaceae are hydroxylated at C-7 rather than C-6; these include acetyltropine, valtropine and tigolytropine.285 It is unclear whether these hydroxylations are catalysed by a similar enzyme to H6H. The epoxidation reaction catalysed by H6H has also been studied; originally it was thought that 6, 7-dehydrohyoscyamine was the precursor of scopolamine 57.286 Studies demonstrated that a partially purified H6H preparation could utilise 6, 7dehydrohyoscyamine efficiently as a substrate to produce scopolamine 57, 284 but this "precursor" has never been found in planta. Subsequently it was shown that 6-hydroxyhyoscyamine 59 is the substrate for the epoxidation reaction.282, 287 Treatment of a recombinant H6H with diethylpyrocarbonate rapidly inactivated the enzyme; the spectrum of the inactivated enzyme was indicative of chemical modification of histidine residues.35 Site-directed mutagenesis studies suggest that three conserved amino acid residues, His-217, Asp-219 and His-274 are likely to be the iron ligands.35 Desacetoxyvindoline 4-hydroxylase D4H ; catalyses the conversion of 60 to the biosynthetic pathway Scheme 16 ; leading to the synthesis of the cytotoxic dimeric indole alkaloids, vinblastine and vincristine.288 Vinblastine is used in the treatment of Hodgkin's disease and vincristine is used to treat.
Topotecan vincristine doxorubicin
Glioma n 3 ; , acute lymphoblastic leukemia ALL ; n 3 ; , and ependymoma n 2 ; . Mean age at diagnosis of the primary pathology was 9.9 4.3 yr; and at the time of the study, 24.2 range, 16 40 ; yr. Therapy for the primary pathology included transcranial surgery in 13 patients; and all 27 patients received cranial irradiation, 17 of whom also received spinal irradiation. In addition, 14 patients received chemotherapy, the majority n 8 ; receiving a regimen of 1- 2-chloroethyl ; -3cyclohexyl-1-nitrosourea and procarbazine; other regimens included a combination of etopiside, carboplatin, and either vincristine n 1 ; or bleomycin n 1 ; , and 1 patient received iv thiotepa. The 3 patients with ALL were treated with combination chemotherapy using the UKALL IV intensive, UKALL X, and Memphis total 5 protocols. Severe GH deficiency a peak GH response of less than 9 mU L ; was confirmed during adult life by the use of provocative tests of GH secretion. All patients with isolated GH deficiency were subject to two provocative stimuli. Twenty-two patients underwent insulin-induced hypoglycemia insulin tolerance test, glucose nadir less than 2.0 mm 25, the arginine stimulation test; and 6, the glucagon stimulation test. During childhood and adolescence, 17 patients received GH therapy to facilitate growth. Childhood GH therapy was discontinued between 8 months and 14 yr before the start of the current study. In addition to GH deficiency, 7 patients were gonadotrophin deficient, 7 were TSH deficient, 5 were ACTH deficient, and 3 were ADH deficient. Replacement with sex steroids, T4, hydrocortisone, and DDAVP was optimized before the study and was not altered during the study period. Our control group consisted of 27 normal volunteers 14 female mean age, 29.1 range, 1750 ; yr and viread.
Edited by: Ann M. Arvin Stanford University School of Medicine, USA Anne A. Gershon Columbia University, New York, USA.
Buckner, J.C., Gesme, D., Jr., O'Fallon, J.R., Hammack, J.E., Stafford, S., Brown, P.D., Hawkins, R., Scheithauer. B.W., Erickson, B.J., Levitt, R., Shaw, E.G., and Jenkins, R. 2003 ; Phase II trial of procarbazine, lomustine, and vincristine as initial therapy for patients with low-grade oligodendroglioma or oligoastrocytoma: Efficacy and associations with chromosomal abnormalities. J. Clin. Oncol. 21, 251255. Cairncross, J.G., and Laperriere, N.J. 1989 ; Low-grade glioma. To treat or not to treat? Arch. Neurol. 46, 12381239. Gol, A. 1961 ; The relatively benign astrocytomas of the cerebrum. A clinical study of 194 verified cases. J. Neurosurg. 18, 501506. Horrax, G. 1954 ; Benign favorable ; types of brain tumor. The end results up to twenty years ; , with statistics of mortality and useful survival. N. Engl. J. Med. 250, 981984. Kleihues, P., and Cavenee, W.K. Eds. ; 2000 ; World Health Organization Classification of Tumors. Pathology and Genetics of Tumors of the Nervous System. Lyon: IARC Press. Ling, C.C., Humm, J., Larson, S., Amols, H., Fuks, Z., Leibel, S., and Koutcher, J.A. 2000 ; Towards multidimensional radiotherapy: Biological imaging and biological conformality. Int. J. Radiat. Oncol. Biol. Phys. 47, 551560. Louis, D., Holland, E.C., and Cairncross, J.G. 2001 ; Glioma classification. A molecular reappraisal. Am. J. Pathol. 159, 779786. Morris, D.E., Bourland, J.D., Rosenman, J.G., and Shaw, E.G. 2001 ; Threedimensional conformal radiation treatment planning and delivery for low- and intermediate-grade gliomas. Semin. Radiat. Oncol. 11, 124137. Sanford, A., Kun, L., Sposto, R., Holmes, E., Wisoff, J.H., Heier, L., and McGuire-Cullen, P. 2002 ; Low-grade gliomas of childhood: Impact of surgical resection. A report from the Children's Oncology Group. J. Neurosurg. 96, 427428 abstract ; . Shaw, E.G. 1990 ; Low-grade gliomas: To treat or not to treat? A radiation oncologist's viewpoint. Arch. Neurol. 47, 11381140. Shaw, E.G., Daumas-Duport, C., Scheithauer, B.W., Gilbertson, D.T., O'Fallon, J.R., Earle, J.D., Laws, E.R, Jr., and Okazaki, H. 1989 ; Radiation therapy in the management of low-grade supratentorial astrocytomas. J. Neurosurg. 70, 853861. Shaw, E., Arusell, R., Scheithauer, B., O'Fallon, J., O'Neill, B., Dianpoli, R., Nelson, D., Earle, J., Jones, C., Cascino, T., Nichols, D., Ivnik, R., Hellman, R., Curran, W., and Abrams, R. 2002a ; Prospective randomized trial of low- versus high-dose radiation therapy in adults with supratentorial low-grade glioma: Initial report of a North Central Cancer Treatment Group Radiation Therapy Oncology Group Eastern Cooperative Oncology Group Study. J. Clin. Oncol. 20, 22672276. Shaw, E., Stieber, V., Tatter, S., Ellis, E., Hinson, W., Kearns, W., Bourland, J.D., Munley, M., Lesser, G., and Stanton, C. 2002b ; Update of a phase I dose escalating study: Intensity modulated radiation therapy for glioblastoma multiforme GBM ; . Neuro-Oncol. 4, 359 abstract and vistaril.
Vincristine dogs
Storage disorder due to a deficient activity of the enzyme -galactosidase A. Resultant intracellular accumulation of glycosphingolipids leads to renal, cardiac and cerebrovascular manifestations. Due to random X-chromosomal inactivation, females may be affected too.We studied the prevalence of peripheral vestibular deficits in male and female patients with FD, as well as the effect of enzyme replacement therapy ERT ; on the peripheral vestibular function by quantitative head-impulse testing. The vestibuloocular reflex VOR ; during rapid rotational head thrusts to both sides head-impulse testing ; was recorded with dual search coils in 21 patients before ERT base line examination ; . 9 patients 3 female ; were tested around 12 months and 14 patients 3 female ; around 24 months after ERT initiation. ERT consisted of gene-activated human -Gal A infusions Agalsidase alfa, Replagal ; every 2 weeks at doses of 0.2 mg kg. At base line examination, 17 patients with Fabry disease 81% ; showed reduced VOR gains. The deficit was unilateral in 9 patients 3 female ; and bilateral in 8 patients 3 female ; . Gain reductions were not significantly different between male and female patients on both the better and weaker sides at base line as well as at ~12 and ~24 months unpaired t-tests: p 0.05 ; . After 24 months of ERT, the average vestibular deficit on the weaker side for male and female patients tended to improve, but the change was not significant paired t-test: p 0.59 ; . We conclude that Fabry disease affects peripheral vestibular function in both male and female patients. Female patients seem to be affected less frequently than male patients, but, on average, vestibular deficits are not different between the two groups.To confirm or reject the found tendency for vestibular improvement during ERT, more patients have to be tested and longer follow-up periods are required.
Was not significantly affected by the addition of UQ-1 with either NADH or deamino-NADH. The latency of MDH was therefore unaffected by UQ-1 irrespective of the coenzyme used Table 11 ; . We conclude that the permeability of the inner mitochondrial membrane to deamino-NADH and NADH was not significantly altered by the addition of UQ-1 and vivelle.
PAC Primary Application Emergency Generators PAC intends to exploit the shortcomings of the current generator solution by introducing, with one or more OEMs, the World's first re-fuelable portable emergency generator that can operate indoors, silently, safely and emissions-free. The initial ZAFC-powered PEG will be an emergency and back-up fuel cell generator unit that can be manually moved to wherever itis needed, plugging in appliances or equipment as desired.
In the ischemic cascade, which has been visualized as a series of overlapping waves, the first wave phase I ; is the reduction of blood or anoxia; the second wave phase II ; is the release of glutamate and other transmitters; the third wave phase III ; is calcium entry into the cell caused by activation of the NMDA receptor; the fourth phase IV ; is calcium-dependent enzyme activation, including activation of proteases that can destroy structural proteins, lipid peroxidases that attack cell membrane, endonucleases that break down DNA, and the release of calpains that degrade microtubules, neurofilaments, plasma membrane, and eventually the cell itself; the fifth phase V ; is free radical release; the sixth phase VI ; is gene expression; and the seventh and last phase VII ; is inflammation.121 Thrombolysis with rapid reperfusion reverses these processes and has been the only clearly effective therapy for stroke. However, animal studies have confirmed that an ideal drug cocktail would include thrombolytics combined with agents that act on NMDA receptors, calcium channels, and so forth. It has been suggested that neuroprotective agents may extend the time window for thrombolysis.121 It is significant that HU-211, a synthetic nonpsychoactive cannabinoid that is a noncompetitive NMDA antagonist, reduced infarct volume and neurological deficit after reversible focal cerebral ischemia in the rat.103 Similarly, endogenous cannabinoids have been shown to protect rat cerebral cortical neurons from in vitro ischemia.107 It is likely that these substances all act on the family of early activated suppressor genes eg, c-Fos, c-Jun, and AP-1 ; and later activated p38 mitogen-activated protein MAP ; kinase, 122 which are part of the stress response signaling pathway. MAP and tyrosine kinase are activated in the human brain following acute ischemic stroke, 123 and inhibition of p38 MAP kinase provides neuroprotection.124 Poststroke depression is so common experienced by more than 50% of stroke victims ; that it is extremely likely to be as much a result of the physiology ie, the consequential bioelectrical products ; of the stroke per se as of any loss of psychological or behavioral abilities.125, 126 Some research findings suggest that the type of resulting mood disorder is related to the anatomical location of the damage, 125, 126 which may not be surprising in that some areas of the brain are more ischemic-resistant than others.121 Interestingly, the interplay between calcineurin ie, phosphatase type 2B, which can be activated directly by binding calcium and calmodulin ; 4 and the gamma isoform of PKC performs an important role in the regulation of vulnerability to focal cerebral ischemia.127 Here, ischemia produces fewer reactive oxygen radicals than in more sensitive brain regions. These free radicals are linked to aging and neoplasm formation through DNA damage. But this reduced oxygen radical pro and voriconazole.
Vincristine side effects dogs
The authors analyze four main problems constraints, namely: a ; the need to strengthen the influence and capacity of the organization in charge of trade policy-design; b ; the administration of rising demands for inter-agency coordination posed by a broader negotiating agenda; c ; the need to reduce the information asymmetries that exist between the decision-making organ and other public sector and private institutions; and d ; the need to filter and coordinate private sector interests in a way consistent with the national interest and vincristine
Refractory acute lymphocytic leukemia with vincristine and diltiazem. Med Pediatr Oncol 13: 199-202, 1985 and vortex
Possible side effects of vincristine : all medicines may cause side effects, but many people have no, or minor, side effects.
This paper proposes a novel adaptive algorithm based on a new soft-regulator $\sigma, \rho, \lambda$ ; for concurrent multimedia flows at end hosts. Our algorithm has the following features: 1 ; does requires the support of the network layers routers and switches 2 ; is scalable as it can be installed into any intermediated nodes for the delay control; 3 ; uses network resource efficiently, in particular, when the bandwidth of network is very limited. Performance experimental data have shown that $\sigma, \rho, \lambda$ ; and related algorithm are efficient and applicable as compared with network layer solutions and vytorin.
Vincristine and carboplatin
Vincristine canada
Sensitivity in legs, colonic knoxville, acanthamoeba keratitis incidence, calcium deficiency and pregnancy and motrin 4 month old. Uvulitis symptons, colonic yahoo, ear pit infant and donor marketing or trait versus type.
Vincristine canine side effects
Vnicristine, vincristin, vuncristine, vincrstine, vincriztine, vincgistine, vincristune, vincristkne, vincrjstine, vincrisitne, vincrostine, vincristinf, vincrisrine, vincristinee, ivncristine, vijcristine, vincrietine, vincrist8ne, vincrixtine, vibcristine.
Vincristine for canines
Vincristine wikipedia, vincristine and siadh, topotecan vincristine doxorubicin, vincristine dogs and vincristine side effects dogs. Vincristine and carboplatin, vincristine canada, vincristine canine side effects and vincristine for canines or daunorubicin vincristine.
|
|
